This session discusses the cultural trends and statistics on tattooing in the United States, along with the physiologic technique of tattooing. Position statements by nephrology organizations regarding the use of tattooing in chronic kidney disease and transplantation is outlined. A full skin exam on persons with tattoos and proper documentation is demonstrated and a list of hazards of tattooing, such as infection, Hepatitis C, Keloid formation, etc. is discussed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures: Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures: Kristin Larson, MSN, RN, AGNP-BC, CNN – Receives salary from United Health Care; Speakers Bureau for Astra Zeneca; ANNA National Secretary.
There are no other speaker disclosures to declare.
Commercial Support: No commercial support declared.
Accreditation Statement: The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome: Upon completion of this activity, the learner will be able to discuss the hazards of tattooing with their CKD patients.